The Current Ratio as of December 2024 (TTM) for Black Diamond Therapeutics, Inc. (BDTX) is 5.55

According to Black Diamond Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.55. This represents a change of -15.52% compared to the average of 6.58 of the last 4 quarters.

Black Diamond Therapeutics, Inc. (BDTX) Historical Current Ratio (quarterly & annually)

How has BDTX Current Ratio performed in the past?

The mean historical Current Ratio of Black Diamond Therapeutics, Inc. over the last ten years is 14.57. The current 5.55 Current Ratio has changed 3.71% with respect to the historical average. Over the past ten years (40 quarters), BDTX's Current Ratio was at its highest in in the March 2020 quarter at 49.60. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Black Diamond Therapeutics, Inc. (BDTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Black Diamond Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Black Diamond Therapeutics, Inc. (BDTX) Average Current Ratio

How has BDTX Current Ratio performed in the past?

The current Current Ratio of Black Diamond Therapeutics, Inc. (BDTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Black Diamond Therapeutics, Inc. (BDTX) Current Ratio vs. Peers

How is BDTX’s Current Ratio compared to its peers?

Black Diamond Therapeutics, Inc.’s Current Ratio is less than Passage Bio, Inc. (0), greater than TCR2 Therapeutics Inc. (5.15), greater than Harpoon Therapeutics, Inc. (2.77), greater than Alector, Inc. (1.89), greater than Revolution Medicines, Inc. (3.29), less than Atreca, Inc. (14.24), greater than Stoke Therapeutics, Inc. (1.58), greater than Homology Medicines, Inc. (5.09), greater than Adaptimmune Therapeutics plc (4.19), greater than null (3.85),

Build a custom stock screener for Black Diamond Therapeutics, Inc. (BDTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Black Diamond Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Black Diamond Therapeutics, Inc. (BDTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Black Diamond Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.